As noted in previous posts I thought the cash burn for the last quarter would be higher due to catch up on paying creditors from the June quarter. This was the case so no surprises and burn in current qtr should drop on this alone.
Like other shareholders I was hoping to get an update including first quarter sales numbers. Wasn't able to attend AGM so they may have given some guidance. Does anyone have any info?
As mentioned previously, from my calculations if sales for Sept qtr this year are equal to Sept qtr last year then this equates to approximately 6.5% sales growth as September qtr 2011 had a few one offs. Hence annual report statement in Impartacus' post would still be true.
Given we are in mid November and the company hasn't indicated the need for funds from shareholders then I assume either cashflow has improved and/or some form of bank facility has been provided/extended.
Hopefully we get a formal business update soon, if not December qtr cash flow and half year accounts should provide the answers. Regardless at a $4.5m market cap I'm happy to hold and see if various contract wins over past 2 years start to drop to the bottom line (ie. healthscope, ALT burettes, medivet etc)
As always DYOR, IMHO etc etc
Add to My Watchlist
What is My Watchlist?